Aldeyra Therapeutics (ALDX) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.35), $0.05 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
